Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells

類似資料

• Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer
  著者:: Foy, Susan P, 等
  出版事項: (2014)
• Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model
  著者:: Foy, Susan P, 等
  出版事項: (2013)
• Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy
  著者:: Mandl, Stefanie J, 等
  出版事項: (2014)
• Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice
  著者:: Foy, Susan P., 等
  出版事項: (2016)
• CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection
  著者:: Waitz, Rebecca, 等
  出版事項: (2012)